Crop Life Science Ratios

Crop Life Science Ltd Ratios

The Crop Life Science Ltd Ratios page provides a complete fundamental analysis of Crop Life Science Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Crop Life Science Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Crop Life Science Ltd (NSE: CLSL, BSE: 79036) is currently trading at ₹45, with a market capitalization of ₹802.15M. As a major player in the Process industries sector and Chemicals: agricultural industry, Crop Life Science Ltd remains a key stock for fundamental analysis using Crop Life Science Ltd Ratios.

Crop Life Science Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Crop Life Science Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Crop Life Science Ltd Ratios.

Historically, the Crop Life Science Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Crop Life Science Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Crop Life Science Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Crop Life Science Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Crop Life Science Ltd P/S ratio currently stands at 0, an important part of Crop Life Science Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Crop Life Science Ltd P/S ratio indicates cautious market sentiment.

Crop Life Science Ltd Price to Cash Flow Ratio (P/CF)

The Crop Life Science Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Crop Life Science Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Crop Life Science Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Crop Life Science Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Crop Life Science Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Crop Life Science Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Crop Life Science Ltd EV/EBITDA ratio is currently 0, a key metric in Crop Life Science Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Crop Life Science Ltd EV/EBITDA indicates balanced valuation.

Crop Life Science Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Crop Life Science Ltd D/E ratio is currently 0.57, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.57
• 2023: 0.49
• 2022: 0.67
• 2021: 0.60

Crop Life Science Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Crop Life Science Ltd ROE currently stands at 7.90%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 7.90
• 2023: 10.73
• 2022: 10.63
• 2021: 8.14

Declining ROE indicates pressure on profitability.

Crop Life Science Ltd Ratios Analysis Summary

The Crop Life Science Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Crop Life Science Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Crop Life Science Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.